| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.003 |